These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26490711)

  • 1. Computational metallomics of the anticancer drug cisplatin.
    Calandrini V; Rossetti G; Arnesano F; Natile G; Carloni P
    J Inorg Biochem; 2015 Dec; 153():231-238. PubMed ID: 26490711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platination of the copper transporter ATP7A involved in anticancer drug resistance.
    Calandrini V; Arnesano F; Galliani A; Nguyen TH; Ippoliti E; Carloni P; Natile G
    Dalton Trans; 2014 Aug; 43(31):12085-94. PubMed ID: 24983998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of in vivo post-translational modifications of the HMGB1 protein upon binding to platinated DNA: a molecular simulation study.
    Lv WL; Arnesano F; Carloni P; Natile G; Rossetti G
    Nucleic Acids Res; 2018 Dec; 46(22):11687-11697. PubMed ID: 30407547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural biology of cisplatin complexes with cellular targets: the adduct with human copper chaperone atox1 in aqueous solution.
    Calandrini V; Nguyen TH; Arnesano F; Galliani A; Ippoliti E; Carloni P; Natile G
    Chemistry; 2014 Sep; 20(37):11719-25. PubMed ID: 25111319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parameterization of azole-bridged dinuclear platinum anticancer drugs via a QM/MM force matching procedure.
    Spiegel K; Magistrato A; Maurer P; Ruggerone P; Rothlisberger U; Carloni P; Reedijk J; Klein ML
    J Comput Chem; 2008 Jan; 29(1):38-49. PubMed ID: 17705162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox-sensitive structural change in the A-domain of HMGB1 and its implication for the binding to cisplatin modified DNA.
    Wang J; Tochio N; Takeuchi A; Uewaki J; Kobayashi N; Tate S
    Biochem Biophys Res Commun; 2013 Nov; 441(4):701-6. PubMed ID: 24427810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling anticancer drug-DNA interactions via mixed QM/MM molecular dynamics simulations.
    Spiegel K; Magistrato A
    Org Biomol Chem; 2006 Jul; 4(13):2507-17. PubMed ID: 16791311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Interactions of High-Mobility Group of Protein Domain B1 with DNA Adducts Generated by Platinum Anticancer Molecules Using In Silico Approaches.
    Misra G; Gupta S; Jabalia N
    Interdiscip Sci; 2018 Sep; 10(3):476-485. PubMed ID: 27900730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA.
    Park S; Lippard SJ
    Biochemistry; 2011 Apr; 50(13):2567-74. PubMed ID: 21355578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reaction of a platinated methionine motif of CTR1 with cysteine and histidine is dependent upon the type of precursor platinum complex.
    Ma G; Wu Q; Wu X; Arnesano F; Natile G; Sletten E; Liu Y
    J Inorg Biochem; 2015 Dec; 153():239-246. PubMed ID: 26235215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein.
    Kasparkova J; Delalande O; Stros M; Elizondo-Riojas MA; Vojtiskova M; Kozelka J; Brabec V
    Biochemistry; 2003 Feb; 42(5):1234-44. PubMed ID: 12564926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Click Chemistry-Based Force Spectroscopy Revealed Enhanced Binding Dynamics of Phosphorylated HMGB1 to Cisplatin-DNA.
    Liu Y; Song D; Li S; Guo Z; Zheng P
    J Am Chem Soc; 2024 May; 146(19):13126-13132. PubMed ID: 38696488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nature of full-length HMGB1 binding to cisplatin-modified DNA.
    Jung Y; Lippard SJ
    Biochemistry; 2003 Mar; 42(9):2664-71. PubMed ID: 12614161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of HMGB1 binding on the structural alterations of platinum drug-treated single dsDNA molecule.
    Mondal S; Banerjee S; Dey D; Lahiri H; Mana T; Jana SS; Mukhopadhyay R
    Biochimie; 2023 Oct; 213():168-175. PubMed ID: 37211256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
    Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
    Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteins that bind to and mediate the biological activity of platinum anticancer drug-DNA adducts.
    Whitehead JP; Lippard SJ
    Met Ions Biol Syst; 1996; 32():687-726. PubMed ID: 8640535
    [No Abstract]   [Full Text] [Related]  

  • 17. Binding of novel azole-bridged dinuclear platinum(II) anticancer drugs to DNA: insights from hybrid QM/MM molecular dynamics simulations.
    Magistrato A; Ruggerone P; Spiegel K; Carloni P; Reedijk J
    J Phys Chem B; 2006 Mar; 110(8):3604-13. PubMed ID: 16494416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the interaction of cisplatin with the human copper chaperone Atox1 by solution and in-cell NMR spectroscopy.
    Arnesano F; Banci L; Bertini I; Felli IC; Losacco M; Natile G
    J Am Chem Soc; 2011 Nov; 133(45):18361-9. PubMed ID: 21981264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin adducts on a GGG sequence within a DNA duplex studied by NMR spectroscopy and molecular dynamics simulations.
    Téletchéa S; Skauge T; Sletten E; Kozelka J
    Chemistry; 2009 Nov; 15(45):12320-37. PubMed ID: 19813235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
    Kasparkova J; Novakova O; Farrell N; Brabec V
    Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.